Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway.

by Konjeti R Sekhar, Jian Wang, Michael L Freeman, Austin N Kirschner
Published 2019-01-01

Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer

by Stephanie O. Dudzinski, Brent D. Cameron, Jian Wang, Jeffrey C. Rathmell, Todd D. Giorgio, Austin N. Kirschner
Published 2019-08-01

Patient Reported Quality of Life Outcomes After Definitive Radiation Therapy With Absorbable Spacer Hydrogel for Prostate Cancer

by Neil B. Newman, MD, MS, Anne Rajkumar, MD, Ryan K. Cleary, MD, Eric T. Shinohara, MD, MSCI, Austin N. Kirschner, MD, PhD
Published 2021-11-01